Taken together, these results showed that BRE activated AKT signaling and inhibited the apoptosis of the ESCC xenograft tumor tissues and indicated that BRE plays an important role in promoting the growth of ESCC in vivo. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.